Worldwide, age-related macular degeneration (AMD) is the leading cause of severe vision loss in people aged 50 or older. Neovascular AMD is an advanced form of the condition, also known as “exudative ...

New treatments for Alzheimer disease don’t reverse cognitive symptoms, but they do significantly slow progression. Evidence suggests that earlier treatment is most effective. In his first ...

An advanced robotic system at The Hospital for Sick Children (SickKids) is changing the way physicians and scientists approach treatments for heart disease. Arrhythmogenic cardiomyopathy (ACM ...

While there's no cure for wet age-related macular degeneration (AMD), there are ways to slow the disease and help you see better for longer. But early detection and timely treatment hold the key ...

Obeticholic acid, which is marketed as Ocaliva as a treatment for a type of liver disease known as primary biliary cholangitis, has come under scrutiny recently. Although the US Food and Drug ...

National Eye Institute: “Treatments for Wet AMD (Advanced Neovascular AMD),” “Injections to Treat Eye Conditions.” CDC: “Prevalence of Age-Related Macular Degeneration (AMD).” ...

This work promotes a new treatment strategy for liver disease that avoids itch side effects. Their findings, entitled “Structure-guided discovery of bile acid derivatives for treating liver ...

With early detection and personalised therapies, Artificial Intelligence (AI) can make a significant mark for the treatment of heart diseases in India, said experts on Sunday. Heart disease is a ...

Monopar Therapeutics has secured an exclusive global license from Alexion Pharmaceuticals to develop and commercialize ALXN-1840, a promising treatment for Wilson disease, following a successful ...

Agomab’s lead candidate is being investigated as a treatment for patients with fibrostenosing Crohn’s disease (FSCD). Credit: Hananeko_Studio via Shutterstock. Agomab Therapeutics has secured $89m in ...